A citation-based method for searching scientific literature

Gareth J Hollands, David P French, Simon J Griffin, A Toby Prevost, Stephen Sutton, Sarah King, Theresa M Marteau. BMJ 2016
Times Cited: 259







List of co-cited articles
427 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Can Communicating Personalised Disease Risk Promote Healthy Behaviour Change? A Systematic Review of Systematic Reviews.
David P French, Elaine Cameron, Jack S Benton, Christi Deaton, Michelle Harvie. Ann Behav Med 2017
76
18

Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours.
Theresa M Marteau, David P French, Simon J Griffin, A T Prevost, Stephen Sutton, Clare Watkinson, Sophie Attwood, Gareth J Hollands. Cochrane Database Syst Rev 2010
197
12


Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations.
Amit V Khera, Mark Chaffin, Krishna G Aragam, Mary E Haas, Carolina Roselli, Seung Hoan Choi, Pradeep Natarajan, Eric S Lander, Steven A Lubitz, Patrick T Ellinor,[...]. Nat Genet 2018
946
11

Lifestyle Advice Combined with Personalized Estimates of Genetic or Phenotypic Risk of Type 2 Diabetes, and Objectively Measured Physical Activity: A Randomized Controlled Trial.
Job G Godino, Esther M F van Sluijs, Theresa M Marteau, Stephen Sutton, Stephen J Sharp, Simon J Griffin. PLoS Med 2016
34
26

Behavioural changes, sharing behaviour and psychological responses after receiving direct-to-consumer genetic test results: a systematic review and meta-analysis.
Kelly F J Stewart, Anke Wesselius, Maartje A C Schreurs, Annemie M W J Schols, Maurice P Zeegers. J Community Genet 2018
35
22

Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
Sarah S Kalia, Kathy Adelman, Sherri J Bale, Wendy K Chung, Christine Eng, James P Evans, Gail E Herman, Sophia B Hufnagel, Teri E Klein, Bruce R Korf,[...]. Genet Med 2017
902
7

Genetic testing for melanoma risk: a prospective cohort study of uptake and outcomes among Australian families.
Nadine A Kasparian, Bettina Meiser, Phyllis N Butow, Judy M Simpson, Graham J Mann. Genet Med 2009
67
10


A systematic review of perceived risks, psychological and behavioral impacts of genetic testing.
Jodi T Heshka, Crystal Palleschi, Heather Howley, Brenda Wilson, Philip S Wells. Genet Med 2008
228
6

Genetic test reporting of CDKN2A provides informational and motivational benefits for managing melanoma risk.
Lisa G Aspinwall, Tammy K Stump, Jennifer M Taber, Danielle M Drummond, Wendy Kohlmann, Marjan Champine, Sancy A Leachman. Transl Behav Med 2018
14
42

Melanoma genetic testing, counseling, and adherence to skin cancer prevention and detection behaviors.
Karen Glanz, Kathryn Volpicelli, Peter A Kanetsky, Michael E Ming, Lynn M Schuchter, Christopher Jepson, Susan M Domchek, Katrina Armstrong. Cancer Epidemiol Biomarkers Prev 2013
28
21

The Tripartite Model of Risk Perception (TRIRISK): Distinguishing Deliberative, Affective, and Experiential Components of Perceived Risk.
Rebecca A Ferrer, William M P Klein, Alexander Persoskie, Aya Avishai-Yitshak, Paschal Sheeran. Ann Behav Med 2016
90
5

A new initiative on precision medicine.
Francis S Collins, Harold Varmus. N Engl J Med 2015
5

Genetic test reporting enhances understanding of risk information and acceptance of prevention recommendations compared to family history-based counseling alone.
Jennifer M Taber, Lisa G Aspinwall, Tammy K Stump, Wendy Kohlmann, Marjan Champine, Sancy A Leachman. J Behav Med 2015
21
23

Unaffected family members report improvements in daily routine sun protection 2 years following melanoma genetic testing.
Lisa G Aspinwall, Jennifer M Taber, Wendy Kohlmann, Samantha L Leaf, Sancy A Leachman. Genet Med 2014
33
15


Polygenic Prediction of Weight and Obesity Trajectories from Birth to Adulthood.
Amit V Khera, Mark Chaffin, Kaitlin H Wade, Sohail Zahid, Joseph Brancale, Rui Xia, Marina Distefano, Ozlem Senol-Cosar, Mary E Haas, Alexander Bick,[...]. Cell 2019
206
5

Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.
Nasim Mavaddat, Kyriaki Michailidou, Joe Dennis, Michael Lush, Laura Fachal, Andrew Lee, Jonathan P Tyrer, Ting-Huei Chen, Qin Wang, Manjeet K Bolla,[...]. Am J Hum Genet 2019
297
5

Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials.
J L Mega, N O Stitziel, J G Smith, D I Chasman, M Caulfield, J J Devlin, F Nordio, C Hyde, C P Cannon, F Sacks,[...]. Lancet 2015
342
5

Effect of personalized nutrition on health-related behaviour change: evidence from the Food4Me European randomized controlled trial.
Carlos Celis-Morales, Katherine M Livingstone, Cyril Fm Marsaux, Anna L Macready, Rosalind Fallaize, Clare B O'Donovan, Clara Woolhead, Hannah Forster, Marianne C Walsh, Santiago Navas-Carretero,[...]. Int J Epidemiol 2017
137
5


The personal and clinical utility of polygenic risk scores.
Ali Torkamani, Nathan E Wineinger, Eric J Topol. Nat Rev Genet 2018
488
5

Clinical use of current polygenic risk scores may exacerbate health disparities.
Alicia R Martin, Masahiro Kanai, Yoichiro Kamatani, Yukinori Okada, Benjamin M Neale, Mark J Daly. Nat Genet 2019
572
5

Effect of direct-to-consumer genomewide profiling to assess disease risk.
Cinnamon S Bloss, Nicholas J Schork, Eric J Topol. N Engl J Med 2011
350
5


A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public.
Amelia K Smit, David Espinoza, Ainsley J Newson, Rachael L Morton, Georgina Fenton, Lucinda Freeman, Kate Dunlop, Phyllis N Butow, Matthew H Law, Michael G Kimlin,[...]. Cancer Epidemiol Biomarkers Prev 2017
29
17

Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting.
Pradeep Natarajan, Robin Young, Nathan O Stitziel, Sandosh Padmanabhan, Usman Baber, Roxana Mehran, Samantha Sartori, Valentin Fuster, Dermot F Reilly, Adam Butterworth,[...]. Circulation 2017
212
5

Psychosocial and behavioral outcomes of genomic testing in cancer: a systematic review.
Tatiane Yanes, Amanda M Willis, Bettina Meiser, Katherine M Tucker, Megan Best. Eur J Hum Genet 2019
30
16

Incorporating a Genetic Risk Score Into Coronary Heart Disease Risk Estimates: Effect on Low-Density Lipoprotein Cholesterol Levels (the MI-GENES Clinical Trial).
Iftikhar J Kullo, Hayan Jouni, Erin E Austin, Sherry-Ann Brown, Teresa M Kruisselbrink, Iyad N Isseh, Raad A Haddad, Tariq S Marroush, Khader Shameer, Janet E Olson,[...]. Circulation 2016
131
5


Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults: Implications for Primary Prevention.
Michael Inouye, Gad Abraham, Christopher P Nelson, Angela M Wood, Michael J Sweeting, Frank Dudbridge, Florence Y Lai, Stephen Kaptoge, Marta Brozynska, Tingting Wang,[...]. J Am Coll Cardiol 2018
255
5

Perceived risk following melanoma genetic testing: a 2-year prospective study distinguishing subjective estimates from recall.
Lisa G Aspinwall, Jennifer M Taber, Wendy Kohlmann, Samantha L Leaf, Sancy A Leachman. J Genet Couns 2014
25
16

Relationships Between Health Literacy and Genomics-Related Knowledge, Self-Efficacy, Perceived Importance, and Communication in a Medically Underserved Population.
Kimberly A Kaphingst, Melvin Blanchard, Laurel Milam, Manusheela Pokharel, Ashley Elrick, Melody S Goodman. J Health Commun 2016
40
10

Genomics is failing on diversity.
Alice B Popejoy, Stephanie M Fullerton. Nature 2016
626
4

Patterns of photoprotection following CDKN2A/p16 genetic test reporting and counseling.
Lisa G Aspinwall, Samantha L Leaf, Wendy Kohlmann, Erin R Dola, Sancy A Leachman. J Am Acad Dermatol 2009
26
15

Measures of sun exposure and sun protection practices for behavioral and epidemiologic research.
Karen Glanz, Amy L Yaroch, Monica Dancel, Mona Saraiya, Lori A Crane, David B Buller, Sharon Manne, David L O'Riordan, Carolyn J Heckman, Jennifer Hay,[...]. Arch Dermatol 2008
238
4

Impact of provision of cardiovascular disease risk estimates to healthcare professionals and patients: a systematic review.
Juliet A Usher-Smith, Barbora Silarova, Ewoud Schuit, Karel G M Moons, Simon J Griffin. BMJ Open 2015
46
8


Public health implications from COGS and potential for risk stratification and screening.
Hilary Burton, Susmita Chowdhury, Tom Dent, Alison Hall, Nora Pashayan, Paul Pharoah. Nat Genet 2013
88
4

Direct-to-Consumer Genetic Testing: User Motivations, Decision Making, and Perceived Utility of Results.
J Scott Roberts, Michele C Gornick, Deanna Alexis Carere, Wendy R Uhlmann, Mack T Ruffin, Robert C Green. Public Health Genomics 2017
65
6

Developing and evaluating complex interventions: the new Medical Research Council guidance.
Peter Craig, Paul Dieppe, Sally Macintyre, Susan Michie, Irwin Nazareth, Mark Petticrew. BMJ 2008
4

Effective techniques in healthy eating and physical activity interventions: a meta-regression.
Susan Michie, Charles Abraham, Craig Whittington, John McAteer, Sunjai Gupta. Health Psychol 2009
4

Genetic essentialism: on the deceptive determinism of DNA.
Ilan Dar-Nimrod, Steven J Heine. Psychol Bull 2011
224
4

Knowing your genes: does this impact behaviour change?
Clare B O'Donovan, Marianne C Walsh, Michael J Gibney, Lorraine Brennan, Eileen R Gibney. Proc Nutr Soc 2017
15
26

BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors.
Andrew Lee, Nasim Mavaddat, Amber N Wilcox, Alex P Cunningham, Tim Carver, Simon Hartley, Chantal Babb de Villiers, Angel Izquierdo, Jacques Simard, Marjanka K Schmidt,[...]. Genet Med 2019
166
4

Implications of Personal Genomic Testing for Health Behaviors: The Case of Smoking.
Emily Olfson, Sarah Hartz, Deanna Alexis Carere, Robert C Green, J Scott Roberts, Laura J Bierut. Nicotine Tob Res 2016
11
36

Communicating genetic risk information for common disorders in the era of genomic medicine.
Denise M Lautenbach, Kurt D Christensen, Jeffrey A Sparks, Robert C Green. Annu Rev Genomics Hum Genet 2013
90
4

Melanoma risk for CDKN2A mutation carriers who are relatives of population-based case carriers in Australia and the UK.
Anne E Cust, Mark Harland, Enes Makalic, Daniel Schmidt, James G Dowty, Joanne F Aitken, Chantelle Agha-Hamilton, Bruce K Armstrong, Jenny H Barrett, May Chan,[...]. J Med Genet 2011
26
15

Pancreatic cancer and melanoma related perceptions and behaviors following disclosure of CDKN2A variant status as a research result.
Emma R Leof, Xuan Zhu, Kari G Rabe, Jennifer B McCormick, Gloria M Petersen, Carmen Radecki Breitkopf. Genet Med 2019
6
66


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.